Tremelimumab is a monoclonal antibody that is specific to cytotoxic T lymphocyte antigen 4 (CTLA-4) and can be used in the study of metastatic melanoma.
- Size: 1mg
- Purity: ≥98%
- Brand: Saint Michael
- Catalogue No.: IT4060-1mg
For laboratory research use only. Not for human or animal consumption, diagnostic or therapeutic use.
Write Your Own Review